Cigarette smoke activates NFκB and induces Muc5b expression in mouse middle ear cells

Laryngoscope

Volumn 118, Issue 3, 2008, Pages 464-471

  Preciado, Diego ^a   Lin, Jezhin ^b   Wuertz, Beverly ^b   Rose, Mary ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cigarette smoke condensate; Mouse middle ear epithelial cells; Muc5b; NF kappaB

Indexed keywords

CIGARETTE SMOKE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCIN; MUCIN 5B; MUCIN-5B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL MODEL; CELL STIMULATION; CELL TYPE; CIGARETTE SMOKING; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; IN VITRO STUDY; MIDDLE EAR; MIDDLE EAR MUCOSA; MOUSE; MUC5B GENE; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; PHYSIOLOGY; SMOKE; TOBACCO;

ANIMALS; CELLS, CULTURED; EAR, MIDDLE; MICE; MUCINS; NF-KAPPA B; SMOKE; TOBACCO;

EID: 42449116611     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31815aedc7     Document Type: Article

References (42)

1. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data 2002;1-32.
2. Rosenfeld RM, Casselbrant ML, Hannley MT. Implications of the AHRQ evidence report on acute otitis media. Otolaryngol Head Neck Surg 2001;125:440-448, discussion 439.
3. U.S. Department of Health and Human Services. The health consequences of involuntary smoking: a report of the Surgeon General. DHHS Publication No. [CDC] 87-8398. Washington, D.C.: U.S. DHHS, Public Health Service, Centers for Disease Control; 1986.
4. Committee on Passive Smoking, Board on Environmental Studies and Toxicology, National Research Council. Environmental tobacco smoke: measuring exposure and assessing health effects. Washington, DC: National Academics Press; 1986.
5. U.S. Environmental Protection Agency. Respiratory health effects of passive smoking: lung cancer and other disorders. Washington, D.C.: USEPA Office of Research and Development; 1992.
6. National Cancer Institute. Health effects of exposure to environmental tobacco smoke: the report of the California Environmental Protection Agency. Smoking and Tobacco Control Monograph No. 10.: US DHHS, National Institutes of Health, National Cancer Institute; 1999.
7. Daly KA, Giebink GS. Clinical epidemiology of otitis media. Pediatr Infect Dis J 2000;19:S31-36.
8. Daly KA, Rovers MM, Hoffman HJ, et al. Recent advances in otitis media. 1. epidemiology, natural history, and risk factors. Ann Otol Rhinol Laryngol Suppl 2005;194:8-15.
9. Dhooge IJ. Risk factors for the development of otitis media. Curr Allergy Asthma Rep 2003;3:321-325.
10. Rovers MM, de Kok IM, Schilder AG. Risk factors for otitis media: an international perspective. Int J Pediatr Otorhinolaryngol 2006;70:1251-1256.
11. Stenstrom C, Ingvarsson L. Otitis-prone children and controls: a study of possible predisposing factors. 2. Physical findings, frequency of illness, allergy, day care and parental smoking. Acta Otolaryngol 1997;117:696-703.
12. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986;46:705-716.
13. Yang SR, Chida AS, Bauter MR, et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006;291:L46-57.
14. Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of Ikappa-Balpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 2003;24:1269-1279.
15. Anto RJ, Mukhopadhyay A, Shishodia S, Gairola CG, Aggarwal BB. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 2002;23:1511-1518.
16. Di Stefano A, Caramori G, Oates T, et al. Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 2002;20:556-563.
17. Barrett TQ, Kristiansen LH, Ovesen T. NF-kappaB in cultivated middle ear epithelium. Int J Pediatr Otorhinolaryngol 2003;67:895-903.
18. Van Seuningen I, Perrais M, Pigny P, Porchet N, Aubert JP. Sequence of the 5′-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells. Biochem J 2000;348 Pt 3:675-686.
19. Monack DM, Mueller A, Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2004;2:747-765.
20. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004;4:953-964.
21. Backert S, Konig W. Interplay of bacterial toxins with host defence: molecular mechanisms of immunomodulatory signalling. Int J Med Microbiol 2005;295:519-530.
22. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 2006;86:245-278.
23. Giebink GS, Le CT, Paparella MM. Epidemiology of otitis media with effusion in children. Arch Otolaryngol 1982;108:563-566.
24. Chung MH, Choi JY, Lee WS, Kim HN, Yoon JH. Compositional difference in middle ear effusion: mucous versus serous. Laryngoscope 2002;112:152-155.
25. Lin J, Tsuboi Y, Rimell F, et al. Expression of mucins in mucoid otitis media. J Assoc Res Otolaryngol 2003;4:384-393.
26. Lin J, Tsuprun V, Kawano H, et al. Characterization of mucins in human middle ear and Eustachian tube. Am J Physiol Lung Cell Mol Physiol 2001;280:L1157-1167.
27. Schousboe LP, Rasmussen LM, Ovesen T. Induction of mucin and adhesion molecules in middle ear mucosa. Acta Otolaryngol 2001;121:596-601.
28. Elsheikh MN, Mahfouz ME. Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion. Laryngoscope 2006;116:365-369.
29. Escande F, Porchet N, Aubert JP, Buisine MP. The mouse Muc5b mucin gene: cDNA and genomic structures, chromosomal localization and expression. Biochem J 2002;363:589-598.
30. Chen Y, Zhao YH, Wu R. In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. Am J Respir Crit Care Med 2001;164:1059-1066.
31. Tsuchiya K, Kim Y, Ondrey FG, Lin J. Characterization of a temperature-sensitive mouse middle ear epithelial cell line. Acta Otolaryngol 2005;125:823-829.
32. Choi JY, Kim CH, Lee WS, Kim HN, Song KS, Yoon JH. Ciliary and secretory differentiation of normal human middle ear epithelial cells. Acta Otolaryngol 2002;122:270-275.
33. Nordskog BK, Fields WR, Hellmann GM. Kinetic analysis of cytokine response to cigarette smoke condensate by human endothelial and monocytic cells. Toxicology 2005;212:87-97.
34. Schick S, Glantz S. Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. Tob Control 2005;14:396-404.
35. Kanno T, Brown K, Siebenlist U. Evidence in support of a role for human T-cell leukemia virus type I Tax in activating NF-kappa B via stimulation of signaling pathways. J Biol Chem 1995;270:11745-11748.
36. Hellermann GR, Nagy SB, Kong X, Lockey RF, Mohapatra SS. Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res 2002;3:22.
37. Ilicali OC, Keles N, De er K, Sa un OF, Guldiken Y. Evaluation of the effect of passive smoking on otitis media in children by an objective method: urinary cotinine analysis. Laryngoscope 2001;111:163-167.
38. Kode A, Yang SR, Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res 2006;7:132.
39. Shao MX, Nakanaga T, Nadel JA. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol 2004;287:L420-427.
40. Takeyama K, Jung B, Shim JJ, et al. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 2001;280:L165-172.
41. Gensch E, Gallup M, Sucher A, et al. Tobacco smoke control of mucin production in lung cells requires oxygen radicals AP-1 and JNK. J Biol Chem 2004;279:39085-39093.
42. Duffey DC, Chen Z, Dong G, et al. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 1999;59:3468-3474.